The Essential

Biotech Rebound Boosts Doris Duke’s Mission-Aligned Portfolio

Life sciences is just one part of the foundation’s impact investment strategy, but the sector’s resurgence helped contribute to strong gains in 2025.

Tiger Cubs Cash In as Stripe’s Valuation Takes Off

A major secondary sale delivers fresh gains to early hedge fund backers.

Sponsored

Asia’s Growing Economic Power Shapes Global Derivatives Market

The Bitcoin Treasury SPAC Market Is Dead

Two once-hot deals, Cantor Equity Partners and ProCapital Financial, have tanked following their DeSPACs.

Related Content

You’re Doing It Wrong: A Tail-Risk Hedger Calls Out His Industry

Julie Segal

Job Board – For Investors Only

Chief Investment Officer (CIO) - Office of the Treasurer & Tax Collector
​

City and County of San Francisco

​
Learn More

Investment Officer (Private Equity), P3
​

United Nations Joint Staff Pension Fund (UNJSPF)

​
Learn More

Director, Pension Accounting and Reporting-Hybrid Schedule
​

Columbia University

​
Learn More

Institutional Investment Consulting Associate
​

Mercer

​
Learn More

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X
Bluesky
Instagram